BELLICUM PHARMACEUTICALS, INC - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 12, 2020

Attached files

file filename
EX-10.35 - EXHIBIT 10.35 - BELLICUM PHARMACEUTICALS, INCexhibit1035_firstamendment.htm
10-K - 10-K - BELLICUM PHARMACEUTICALS, INCa201910k1.htm
EX-32.2 - EXHIBIT 32.2 - BELLICUM PHARMACEUTICALS, INCexh322certcfosox2019q4.htm
EX-32.1 - EXHIBIT 32.1 - BELLICUM PHARMACEUTICALS, INCexh321certceosox2019q4.htm
EX-31.2 - EXHIBIT 31.2 - BELLICUM PHARMACEUTICALS, INCexh312certofcfo2019q4.htm
EX-31.1 - EXHIBIT 31.1 - BELLICUM PHARMACEUTICALS, INCexh311certofceo2019q4.htm
EX-21.1 - EXHIBIT 21.1 - BELLICUM PHARMACEUTICALS, INCbellicum-ex211subsidiaries19.htm
EX-10.5(B) - EXHIBIT 10.5(B) - BELLICUM PHARMACEUTICALS, INCexhibit105b_2019equityince.htm
EX-10.39 - EXHIBIT 10.39 - BELLICUM PHARMACEUTICALS, INCexhibit1039_firstamendment.htm
EX-10.38 - EXHIBIT 10.38 - BELLICUM PHARMACEUTICALS, INCexhibit1038_mdaassetpurcha.htm
EX-10.6 - EXHIBIT 10.6 - BELLICUM PHARMACEUTICALS, INCexhibit106_directorcompens.htm
EX-4.7 - EXHIBIT 4.7 - BELLICUM PHARMACEUTICALS, INCexhibit47_descriptionofsec.htm
EX-3.1 - EXHIBIT 3.1 - BELLICUM PHARMACEUTICALS, INCexhibit31_amendedrestatedc.htm
Exhibit 23.1


Consent of Independent Registered Public Accounting Firm


We consent to the incorporation by reference in the following Registration Statements:

(1)
Registration Statements (Form S-3 Nos. 333-219020, 333-226652, and 333-232771) of Bellicum Pharmaceuticals, Inc., and
(2)
Registration Statements (Form S-8 Nos. 333-201036, 333-216656, 333-218772, 333-220170, 333-223636, 333-225554, 333-231272, 333-232304, 333-232774, and 333-236149) pertaining to the 2006 Stock Option Plan, 2011 Stock Option Plan, 2014 Equity Incentive Plan, as amended, 2014 Employee Stock Purchase Plan, and 2019 Equity Incentive Plan of Bellicum Pharmaceuticals, Inc.

of our reports dated March 12, 2020, with respect to the consolidated financial statements of Bellicum Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Bellicum Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Bellicum Pharmaceuticals, Inc. for the year ended December 31, 2019.

/s/ Ernst & Young LLP


Houston, Texas
March 12, 2020


BELLICUM PHARMACEUTICALS, INC Reports